Related Experiment Videos
Glucose-stimulated insulin secretion: A newer perspective
Mitsuhisa Komatsu1, Masahiro Takei1, Hiroaki Ishii1
1Department of Internal Medicine Division of Diabetes, Endocrinology and Metabolism Shinshu University School of Medicine Matsumoto Nagano Japan.
Journal of Diabetes Investigation
|May 21, 2014
Summary
Glucose-stimulated insulin secretion (GSIS) involves more than just KATP channels. In vivo, other signals prime beta-cells for robust insulin release, suggesting a revised model for GSIS physiology.
Area of Science:
- Endocrinology
- Cellular Physiology
- Metabolic Research
Background:
- Conventional models of glucose-stimulated insulin secretion (GSIS) primarily rely on in vitro studies using high glucose levels.
- These models often focus on the adenosine triphosphate-sensitive K(+) channel (KATP channel)-dependent mechanism.
- However, the in vivo physiological context involves multiple co-stimulatory signals influencing beta-cell function.
Purpose of the Study:
- To propose a newer perspective on the physiological understanding of GSIS.
- To challenge the conventional KATP channel-centric model of GSIS.
- To integrate existing knowledge and formulate a hypothesis for in vivo GSIS.
Main Methods:
- Overview of existing concepts and models for GSIS.
- Analysis of in vitro data and comparison with in vivo physiological conditions.
- Hypothesis formulation based on the role of co-stimulatory signals and KATP channel-independent pathways.
Main Results:
- In vivo, beta-cells are constantly exposed to stimulatory signals like GLP-1, parasympathetic inputs, and nutrients.
- These signals, including cyclic adenosine monophosphate and protein kinase C activation, prime beta-cells for glucose responsiveness.
- GSIS can occur independently of direct glucose regulation of KATP channels, supported by studies on KATP channel mutations.
Conclusions:
- A revised hypothesis suggests that in vivo GSIS relies on beta-cell priming by various stimulatory inputs, not solely glucose acting on KATP channels.
- Activation of cyclic adenosine monophosphate and protein kinase C pathways, along with non-glucose nutrients, are crucial for KATP channel-independent GSIS.
- A comprehensive integration of knowledge is required for a complete understanding of GSIS physiology.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Glucagon-like Receptor Agonists
820
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
820
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
Oral Hypoglycemic Agents: Glinides
572
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
572
Insulin: The Receptor and Signaling Pathways
2.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.7K